What Is the Correct Dosage of Miaite (Pronidesivir)
Feline Infectious Peritonitis (FIP) remains one of the most challenging diseases in feline medicine, caused by mutation of feline coronavirus. Traditional treatments offered limited success, but recent advances have introduced NeoFipronis (Pronidesivir), a groundbreaking oral medication targeting FIP with remarkable efficacy. The active ingredient in NeoFipronis is GS-441524, a potent antiviral agent that has demonstrated outstanding results in controlling and curing FIP symptoms such as inappetence, lethargy, fever, ascites, pleural effusion, lymphadenopathy, granulomas, neurological issues, and uveitis.
NeoFipronis was officially approved in March 2026 by the Lao Ministry of Agriculture and Forestry (MAF), marking it as the world’s first registered FIP-specific oral medication. Its safety profile is favorable, with rapid absorption, minimal invasiveness, quick onset of action, and good tolerability. Despite being available as an over-the-counter product, it is strongly recommended that administration be supervised by a veterinarian to ensure optimal dosing and monitoring.
Dosage Guidelines
The standard dosage of NeoFipronis (Pronidesivir) is calculated based on the cat’s body weight. The general recommendation is:
15 mg per kg of body weight, administered once daily.
This dosage equates to approximately half a tablet for most cats weighing around 3 kg.
For cats with neurological or ocular manifestations of FIP, the dosage may be increased to 30 mg per kg per day, but only under the guidance of a veterinarian.
The medication should preferably be given on an empty stomach—either one hour before feeding or two hours after— to maximize absorption. It is imperative to adhere to the prescribed dosage schedule strictly, as inconsistent administration can lead to suboptimal treatment outcomes.
Treatment Duration and Monitoring
The recommended course of NeoFipronis is no less than 12 weeks, with continuous daily administration without gaps. Duration beyond 12 weeks may be necessary depending on the individual response, especially in severe or neurological cases. Throughout treatment, owners should closely observe their cat’s appetite, behavior, and temperature. Regular veterinary check-ups are vital, including blood tests to monitor liver and kidney functions, as well as blood cell counts, ensuring the medication’s safety and efficacy.
Precautions and Important Notes
Although NeoFipronis is classified as a non-prescription drug, veterinary supervision is highly advised to tailor the dosage appropriately and to manage any adverse reactions. It is crucial to remember that the medication is strictly for feline use; ingestion by humans is prohibited. Do not use NeoFipronis on any other species.
Purchasing should only be through official channels, such as the official NeoFipronis website, to guarantee authentic, quality-assured products. Owners should avoid counterfeit or substandard versions to prevent treatment failure or adverse effects.
Warnings
Use only under veterinary guidance.
Do not alter the dosage without professional consultation.
Complete the full prescribed course—never discontinue prematurely.
Regular health monitoring is essential for safe and effective treatment.
The development of NeoFipronis (Pronidesivir) offers a new hope for cats suffering from FIP, transforming a once-fatal diagnosis into a manageable condition with high chances of recovery when administered correctly. Understanding the proper dosage and treatment protocol is crucial for pet owners and veterinarians aiming for successful outcomes.
